https://investor.armatapharma.com/ https://investor.armatapharma.com/2026-06-23-Armata-Pharmaceuticals-Receives-2-5-Million-of-Additional-Non-Dilutive-Award-Funding-from-the-U-S-Department-of-Defense-to-Support-AP-SA02 Tue, 23 Jun 2026 07:00:00 -0400 https://investor.armatapharma.com/2026-06-23-Armata-Pharmaceuticals-Receives-2-5-Million-of-Additional-Non-Dilutive-Award-Funding-from-the-U-S-Department-of-Defense-to-Support-AP-SA02 https://investor.armatapharma.com/2026-05-13-Armata-Pharmaceuticals-Announces-First-Quarter-2026-Results-and-Provides-Corporate-Update Wed, 13 May 2026 16:30:00 -0400 https://investor.armatapharma.com/2026-05-13-Armata-Pharmaceuticals-Announces-First-Quarter-2026-Results-and-Provides-Corporate-Update https://investor.armatapharma.com/2026-05-07-Armata-Pharmaceuticals-Secures-FDA-Fast-Track-Designation-for-AP-SA02 Thu, 07 May 2026 07:00:00 -0400 https://investor.armatapharma.com/2026-05-07-Armata-Pharmaceuticals-Secures-FDA-Fast-Track-Designation-for-AP-SA02 https://investor.armatapharma.com/2026-05-04-Armata-Pharmaceuticals-Announces-Structural-Biology-Publication-in-Communications-Biology Mon, 04 May 2026 07:00:00 -0400 https://investor.armatapharma.com/2026-05-04-Armata-Pharmaceuticals-Announces-Structural-Biology-Publication-in-Communications-Biology https://investor.armatapharma.com/2026-04-27-Armata-Pharmaceuticals-Announces-Appointment-of-Biopharmaceutical-Commercial-Executive-Daniel-B-Gilmer,-Ph-D-to-its-Board-of-Directors Mon, 27 Apr 2026 07:00:00 -0400 https://investor.armatapharma.com/2026-04-27-Armata-Pharmaceuticals-Announces-Appointment-of-Biopharmaceutical-Commercial-Executive-Daniel-B-Gilmer,-Ph-D-to-its-Board-of-Directors